Home › Companies › AURINIA PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and AURINIA PHARMACEUTICALS INC.’s Form 8-K, filed 2025-05-15 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AURINIA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are AURINIA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Mr. Kevin Tang | 66,060,648 | -- | -- | 10,860,057 | 16,871,274 | Majority: yes |
| Elect Director: Mr. Jeffrey A. Bailey | 58,403,787 | -- | -- | 18,516,917 | 16,871,275 | Majority: yes |
| Elect Director: Ms. Kathy L. Goetz | 61,844,787 | -- | -- | 15,075,919 | 16,871,273 | Majority: yes |
| Elect Director: Mr. Peter Greenleaf | 59,168,775 | -- | -- | 17,751,929 | 16,871,275 | Majority: yes |
| Elect Director: Mr. Craig Johnson | 61,670,962 | -- | -- | 15,249,743 | 16,871,274 | Majority: yes |
| Elect Director: Ms. Tina S. Nova | 60,967,841 | -- | -- | 15,952,864 | 16,871,274 | Majority: yes |
| Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of sharehol | 88,332,423 | -- | -- | 5,459,552 | 4 | Majority: yes |
| Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation. | 58,851,313 | 17,180,345 | 889,047 | -- | 16,871,274 | Majority: yes |
| Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan. | 48,215,063 | 28,374,579 | 331,064 | -- | 16,871,273 | Majority: yes |
Source: AURINIA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2025-05-15 — read the filing on EDGAR.
Each item below shows how the 190 asset managers that disclosed a AURINIA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AURINIA PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 10 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”): 58,851,313 for, 17,180,345 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 43% for, 12% against (55% of the company cast a for/against vote).
The 182 asset managers below cast 97% of the shares they voted on this item FOR (44,514,917 for, 1,181,665 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 10,029,500 | 0 | 0 | 0 | For |
| BlackRock | 5,930,345 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 3,969,834 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 3,062,840 | 0 | 0 | 0 | For |
| State Street | 2,245,473 | 0 | 0 | 0 | For |
| Vanguard | 2,096,839 | 0 | 0 | 0 | For |
| Fidelity | 1,319,290 | 0 | 0 | 0 | For |
| Nuveen | 1,245,549 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,200,783 | 0 | 0 | 0 | For |
| Charles Schwab | 1,049,656 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 926,779 | 0 | 0 | 0 | For |
| Northern Trust | 897,550 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 861,284 | 0 | 0 | 0 | For |
| Lazard | 720,994 | 0 | 0 | 0 | For |
| Goldman Sachs | 656,522 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 513,441 | 0 | 0 | 0 | For |
| American Century | 0 | 477,301 | 0 | 0 | Against |
| Woodline Partners LP | 427,239 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 375,639 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 0 | 357,000 | 0 | Abstain |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Renaissance | 313,423 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 279,436 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 266,498 | 0 | 0 | 0 | For |
Showing the 25 largest of 182 asset managers. See all 182 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm unti”): 88,332,423 for, 5,459,552 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 64% for, 4% withheld (68% of the company cast a for/withheld vote).
The 49 asset managers below cast 100% of the shares they voted on this item FOR (12,308,442 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 357,000 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 4 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Kevin Tang”): 66,060,648 for, 10,860,057 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 48.0% for, 8% withheld (56% of the company cast a for/withheld vote).
The 49 asset managers below cast 100% of the shares they voted on this item FOR (12,343,209 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 357,000 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Craig Johnson”): 61,670,962 for, 15,249,743 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 45% for, 11% withheld (56% of the company cast a for/withheld vote).
The 48 asset managers below cast 100% of the shares they voted on this item FOR (11,986,209 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Jeffrey A. Bailey”): 58,403,787 for, 18,516,917 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 42% for, 13% withheld (56% of the company cast a for/withheld vote).
The 48 asset managers below cast 100% of the shares they voted on this item FOR (11,629,853 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 236,765 | 0 | Abstain |
| Lincoln Financial | 72,668 | 0 | 98,700 | 0 | Abstain |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 5 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ms. Kathy L. Goetz”): 61,844,787 for, 15,075,919 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 45% for, 11% withheld (56% of the company cast a for/withheld vote).
The 48 asset managers below cast 100% of the shares they voted on this item FOR (11,986,209 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Peter Greenleaf”): 59,168,775 for, 17,751,929 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 43% for, 13% withheld (56% of the company cast a for/withheld vote).
The 48 asset managers below cast 100% of the shares they voted on this item FOR (11,986,209 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ms. Tina S. Nova”): 60,967,841 for, 15,952,864 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 44% for, 12% withheld (56% of the company cast a for/withheld vote).
The 48 asset managers below cast 100% of the shares they voted on this item FOR (11,826,739 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 0 | 0 | 89,783 | 0 | Abstain |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 69,687 | 0 | Abstain |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
63% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan.”): 48,215,063 for, 28,374,579 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 35% for, 21% against (56% of the company cast a for/against vote).
The 31 asset managers below cast 96% of the shares they voted on this item FOR (6,500,850 for, 251,899 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| American Century | 0 | 238,445 | 0 | 0 | Against |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 159,707 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
| Pacific Life | 48,810 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 48,262 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 37,051 | 0 | 0 | 0 | For |
| ProShares | 31,437 | 0 | 0 | 0 | For |
| DWS | 20,916 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| Calvert | 0 | 13,454 | 0 | 0 | Against |
| AQR | 12,319 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan.”): 48,215,063 for, 28,374,579 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 35% for, 21% against (56% of the company cast a for/against vote).
The 19 asset managers below cast 93% of the shares they voted on this item FOR (5,164,184 for, 391,509 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 357,000 | 0 | 0 | Against |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 36,103 | 34,509 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 45,900 | 0 | 0 | 0 | For |
| John Hancock | 45,791 | 0 | 0 | 0 | For |
| New York Life | 26,909 | 0 | 0 | 0 | For |
| SEI | 25,100 | 0 | 0 | 0 | For |
| Prudential/PGIM | 21,700 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 18,900 | 0 | 0 | 0 | For |
| Nationwide | 6,114 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 2,910 | 0 | 0 | 0 | For |
| BRANDYWINE OAK PRIVATE WEALTH LLC | 500 | 0 | 0 | 0 | For |
| Principal | 282 | 0 | 0 | 0 | For |
77% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”): 58,851,313 for, 17,180,345 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 137,747,000 outstanding shares: 43% for, 12% against (55% of the company cast a for/against vote).
The 6 asset managers below cast 53.4% of the shares they voted on this item FOR (409,822 for, 357,000 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 370,547 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 357,000 | 0 | 0 | Against |
| GuideStone | 35,267 | 0 | 0 | 0 | For |
| Jasper Ridge Partners, L.P. | 3,863 | 0 | 0 | 0 | For |
| TD ASSET MANAGEMENT INC | 125 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 20 | 0 | 0 | 0 | For |
Ranked by the number of AURINIA PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 137,747,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 7.28% |
| 2 | BlackRock | 4.31% |
| 3 | NEA Management Company, LLC | 2.88% |
| 4 | ARMISTICE CAPITAL, LLC | 2.22% |
| 5 | State Street | 1.63% |
| 6 | Vanguard | 1.52% |
| 7 | Fidelity | 0.96% |
| 8 | Nuveen | 0.90% |
| 9 | TIAA | 0.90% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.87% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 9.47% | 13D |
| BlackRock | 6.36% | 13F |
| Chin Kyu Huh | 4.74% | 13D |
| State Street | 2.07% | 13F |
| Morgan Stanley | 1.72% | 13F |
| Vanguard Group | 1.43% | 13F |
| Geode Capital | 1.26% | 13F |
| Goldman Sachs | 1.18% | 13F |
| Nuveen | 1.08% | 13F |
| Northern Trust | 0.75% | 13F |
Percentages above are of 137,747,000 shares outstanding, as reported by AURINIA PHARMACEUTICALS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AURINIA PHARMACEUTICALS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AURINIA PHARMACEUTICALS INC.'s shareholder meeting held 2025-05-15, in the 2024-2025 proxy season, 190 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,456 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a… — FOR was 77% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AURINIA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-15.
AURINIA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.